Sehn, L. H. Et Al. 2020. Polatuzumab Vedotin Plus Bendamustine and Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Updated Results of a Phase Ib/II Randomized Study and Preliminary Results of a Single-Arm Extension. BLOOD , vol.136, no.Supplement 1 , 17-19.

Sehn, L. H., Hertzberg, M., Opat, S., Herrera, A. F., Assouline, S. E., Flowers, C., ... Kim, T. M.(2020). Polatuzumab Vedotin Plus Bendamustine and Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Updated Results of a Phase Ib/II Randomized Study and Preliminary Results of a Single-Arm Extension. BLOOD , vol.136, no.Supplement 1, 17-19.

Sehn, Laurie Et Al. "Polatuzumab Vedotin Plus Bendamustine and Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Updated Results of a Phase Ib/II Randomized Study and Preliminary Results of a Single-Arm Extension," BLOOD , vol.136, no.Supplement 1, 17-19, 2020

Sehn, Laurie H. Et Al. "Polatuzumab Vedotin Plus Bendamustine and Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Updated Results of a Phase Ib/II Randomized Study and Preliminary Results of a Single-Arm Extension." BLOOD , vol.136, no.Supplement 1, pp.17-19, 2020

Sehn, L. H. Et Al. (2020) . "Polatuzumab Vedotin Plus Bendamustine and Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Updated Results of a Phase Ib/II Randomized Study and Preliminary Results of a Single-Arm Extension." BLOOD , vol.136, no.Supplement 1, pp.17-19.

@article{article, author={Laurie H. Sehn Et Al. }, title={Polatuzumab Vedotin Plus Bendamustine and Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Updated Results of a Phase Ib/II Randomized Study and Preliminary Results of a Single-Arm Extension}, journal={BLOOD}, year=2020, pages={17-19} }